Article Competing interests


these patients, as well as an aggressive atti- tude towards metastasis, with radical surgical exertion of the tumour being, whenever it is possible, the authors’ choice.


Consent Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.


The authors did not receive any outside fund- ing or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. The author(s) declare that they have no competing interests’.


Authors’ contributions MRS: acquisition of data, data analysis


and manuscript drafting, MSC: acquisi- tion of data, data analysis and manuscript drafting, PCR: acquisition of data, data analysis, NN: analysis and interpretation of data, revising, AMG: analysis and in- terpretation of data, revising, RP: analysis and interpretation of data, revising, DC ac- quisition of data, analysis and interpreta- tion of data, revising. All authors read and approved the final manuscript.


References 1


Neumann HPH, et al.: Pheocromocytoma. In Harrison’s Principles of internal medicine. Vol 2. 17th edition. Edited by Fauci . McGraw Hill Medical; 337: 2269–2275


2


Kimura N, Chetty R, Capella C, Young WF, Koch CA, Lam KY, DeLellis RA, Kawashima A, Komminoth P, Tischler AS: Extra-adre- nal paraganglioma: carotid body, jugulotympanic, vagal, laryngeal, aortico-pulmonary. In World Health Organization classification of tumours pathology and genetics: tumours of endocrine organs. Ed- ited by DeLelis RA, Lloyd RV, Heitz PU, Eng C. IARC Press, Lyon France; 2004:159-161.


3


Neumann HP, Pawlu C, Bausch B, Peczkowska M, McWhinney SR, Muresane M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C: Dis- tinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 294:943-951.


4


Schiavi F, Boedeker CC, Bausch B, Peczkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM, Berlis A, Brink I, Cybulla M, Muresan M, Walter MA, Forrer F, Vali- maki M, Kawecki A, Szutkowski Z, Schipper J, Walz MK, Pigny P, Bauters C, Willet-brozick JE, Baysal BE, Januszewicz A, Eng C, Opocher G, Neumann HPH: Predictors and prevalence of para- ganglioma syndrome associated with mutations of the SDHB and SDHD. JAMA 2005, 294:2057-2063.


5


Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PLM, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG: Clinical pre- sentations and penetrance of pheochromocytoma and paraganglioma syndromes. J Clin Endocrinol Metab 2006, 91:827-836.


6


Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treir M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigiel- ski C, Eng : Germ line mutations in nonsyndromic pheochromocy- toma. N Engl J Med 2002, 346:1459-1466.


7


Baush B, Borozdin W, Mautner VF, Hoffmann MM, Boehm D, Ro- bledo M, Cascon A, Harenberg T, Schiavi F, Pawlu C, Peczkowska M, Letizia C, Calvieri S, Arnaldi G, Klingenberg-Noftz RD, Reisch N, Fassina A, Brunaud L, Walter MA, Mannelli M, MacGregor G, Palazzo FF, Barontini M, Walz MK, Kremens B, Brabant G, Pfaf-


24 | SpinalSurgeryNews | Autumn 2012


fle R, Koschker AC, Lohoefner F, Mohaupt M, Gimm O, Jarzab B, McWhinney SR, Opocher G, Januszewicz A, Kohlhase J, Eng C, Neumann HP: Germline NF1 mutational spectra and loss of hetero- zigosity analyses in patients with pheochromocytoma and neurofi- bromatosis type 1. J Clin Endocrinol Metab 2007, 92:2784-2792.


8


Baysal BE, Ferrel RE, Willet-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, Van der Mey A, Taschner PEM, Rubinstein Meyers EN, Richard CW, Cornelisse CJ, Devilee P, Devlin B: Mutations in SDHD, a mitocondrial complex II gene, in hereditary paraganglio- ma. Science 2000, 287:848-851.


9


Niemann S, Muller U: Mutations in SDHC cause autosomal domi- nant paraganglioma, type 3. Nat Genet 2000, 26:268-270.


10


Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skold- berg F, Husebye ES, Eng C, Maher ER: Gene mutations in the suc- cinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and familial paraganglioma. Am J Hum Gent 2001, 69:49-54.


11


Lloyd RV, Kovacs K, Young WF, Farrell WF, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheitauher BW, Horvath E: Pituitary tu- mours: Introduction. In World Health Organization classification of tumours pathology and genetics: tumours of endocrine organs. Ed- ited by DeLelis RA, Lloyd RV, Heitz PU, Eng C. IARC Press, Lyon France; 2004:10-13.


12 13


Young WF: Paragangliomas: clinical overview. Annals of the New York Academy of Science 2006, 1073:21-29.


Manneli M: Management and Treatment of Pheochromocytomas and Paragangliomas. Annals of the New York Academy of Science 2006, 1073:405-416.


14


Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K: Biochemical diagnosis of paraganglioma: how to distinguish true from false positive test results. J Clin Endocrinol Metab 2003, 88(6):2656-2666.


15 16


Olson JJ, Loftus CM, Hitchon PW: Metastatic pheochromocytoma of the cervical spine. Spine 1989, 14(3):349-351.


Noruma K, Kimura H, Shimizu S, Kodama H, Okamoto T, Obara T, Takano K: Survival of patients with metastatic malignat pheochro- mocytoma and efficacy of combined cyclosphosphamide, vincris- tine, and dacarbazine chemotherapy. JCEM 2009, 94:2850-2856.


17


Erlic Z, Neumann HPH: Clinical questions: when should genetic testing be obtained in a patient with pheochromocytoma or paragan- glioma? Clin Endocrinol 2009, 70:354-357.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36